Literature DB >> 25901414

Sentrin/small ubiquitin-like modifier-specific protease 5 protects oral cancer cells from oxidative stress-induced apoptosis.

Yong Cheng1, Xuehua Guo1, Yiming Gong1, Xiaojun Ding1, Youcheng Yu1.   

Abstract

The aim of the present study was to investigate the role of sentrin/small ubiquitin-like modifier (SUMO)-specific protease 5 (SENP5) in oral squamous cell carcinoma (OSCC), as the overexpression of SENP5 has been observed in 31 OSCC tissue specimens. CAL-27 OSCC cells were used for in vitro measurements. The distribution of SENP5 was visualized using immunohistochemistry and H2O2-induced oxidative stress, and the effects of SENP-small interfering RNA on SENP5 were analyzed via western blotting. The apoptotic rates of the CAL-27 cells during oxidative stress and SENP5 silencing were estimated using flow-cytometry, and the mitochondrial structures were analyzed using a mitochondria tracker. The SENP5 protein was localized in the nuclei and cytosols of the CAL-27 cells, and incubation with 100 µm H2O2 for >1 h led to its stabilization. Incubation with H2O2 alone had no effect on the CAL-27 cells, however, a combination of H2O2 and SENP5 silencing led to enhanced apoptotic rates (P<0.001). Analysis of the mitochondrial structures revealed that H2O2 alone enhanced mitochondrial network formation, whereas the combination of H2O2 and SENP5 silencing led to mitochondrial fragmentation in the CAL-27 cells. The overexpression of SENP5 partly localized in the cytosol of the OSCC cells. Mild oxidative stress stabilized the SENP5 protein in the CAL-27 cells, and only the combination of SENP5 silencing and H2O2 application led to mitochondria fragmentation and a significant increase in cell apoptosis. Therefore, SENP5 protected the OSCC cells from oxidative stress-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25901414     DOI: 10.3892/mmr.2015.3662

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  4 in total

Review 1.  SENP Proteases as Potential Targets for Cancer Therapy.

Authors:  Paulina Tokarz; Katarzyna Woźniak
Journal:  Cancers (Basel)       Date:  2021-04-24       Impact factor: 6.639

Review 2.  Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.

Authors:  Nieves Lara-Ureña; Vahid Jafari; Mario García-Domínguez
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

3.  Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation.

Authors:  Jingjing Wu; Hu Lei; Jinfu Zhang; Xiangyun Chen; Caixia Tang; Weiwei Wang; Hanzhang Xu; Weilie Xiao; Wenli Gu; Yingli Wu
Journal:  Oncotarget       Date:  2016-09-13

Review 4.  SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer.

Authors:  Karolin Eifler; Alfred C O Vertegaal
Journal:  Trends Biochem Sci       Date:  2015-10-22       Impact factor: 13.807

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.